For healthcare providers, this means access to a tool capable of achieving outcomes previously thought impossible with pharmacotherapy alone
Cardiovasc Diabetol 16:48 Tanaka A, Shimabukuro M, Machii N, Teragawa H, Okada Y, Shima KR, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M, Ueda S, Higashi Y, Node K (2020) Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial
These can include nausea, vomiting of undigested food, abdominal pain, bloating, severe dehydration, a sense of fullness after only a few bites, solidification of undigested food within the stomach, acid reflux, fluctuating blood sugar readings, reduced appetite, weight loss, undernutrition, and a diminished overall quality of life
Otros efectos secundarios que enumera la FDA son: dolor de cabeza, fatiga, indigestin, mareos, distensin abdominal, flatulencia, gastroenteritis y enfermedad por reflujo gastroesofgico
WE TALK ABOUT THIS IN POWERLIFTING, WHICH I COMPETE IN A LOT OF TIMES